Skip to main content
Joseph McGuirk, DO, Oncology, Kansas City, KS

JosephPatrickMcGuirkDO

Oncology • Kansas City, KS

Medical Director, Blood and Marrow Transplant and Professor of Medicine, The University of Kansas Medical Center

Join to view full profile

Dr. McGuirk is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. McGuirk's full profile

Already have an account?

  • Office

    3901 Rainbow Blvd
    Kansas City, KS 66160
    Phone+1 913-588-6030
    Fax+1 913-588-4085

Summary

  • Joseph McGuirk, DO, has been a principal investigator in more than 49 clinical trials and has authored or co-authored more than 300 publications, abstracts, oral presentations and posters. He has presented at dozens of universities and associations, including Dana-Farber Cancer Center and Beth Israel Hospital in Boston, the Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing, the American Society of Hematology Annual Meeting,
    the Kansas Association of Osteopathic Medicine, AABB (American Association of Blood Banks) and AACR (American Association for Cancer Research). He is also a member of numerous cancer center committees, including blood utilization, multidisciplinary cancer, graft sources, infection prevention and hematology/BMT disease working
    groups and is the Chair for RITN Working Committee, KC Round Table of Hematology and Oncology, and Cancer Pharmacy and Therapeutics.


    Dr. McGuirk completed his residency at Yale and his fellowship training at Memorial Sloan-Kettering Cancer Center in New York City and subsequently served as Associate Director of the Yale Stem Cell Transplant Program. He served as medical director of Kansas City Cancer Center’s blood and marrow transplant program at St. Luke’s Hospital before joining The University of Kansas Cancer Center in 2007. He currently serves as Director for the Division of Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Cancer Center and holds the endowed Schutte-Speas Professorship in Hematology-Oncology. Also, he currently serves on the ASTCT Board of Directors as a Director and Chairs the AACI National CAR-T initiative.


    He is currently serving on over 25 national journals on Advisory Boards and Editorial Boards. He has been invited to present, Co-Chair, and Chair all over the United States and Internationally in Russia, China, and Switzerland and his publications have been presented internationally, nationally, and locally.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1993 - 1996
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1990 - 1993
  • Kansas City University of Medicine and Biosciences College of Osteopathic Medicine
    Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 1990
  • University of Missouri
    University of MissouriBA, Biology, 1986

Certifications & Licensure

  • KS State Medical License
    KS State License 2002 - 2025
  • MO State Medical License
    MO State License 1999 - 2025
  • CT State Medical License
    CT State License 1997 - 1999
  • SC State Medical License
    SC State License 1996 - 1998
  • NY State Medical License
    NY State License 1993 - 1996
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Hall of Fame Catalyst Award University of Kansas Health System, 2017
  • Clinical Science Award The University of Kansas Cancer Center Director, 2017
  • Innovations Award National Marrow Donor Program (R), 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated Donors  
    Parameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica
  • In Vivo Purging May Not be Required in the Era of Universal Use of Rituximab Containing Chemo Immunotherapy in Patients with Follicular and Mantle Cell Lymphoma: A Sin...  
    Anurag K Singh, Clint Divine, Omar Aljitawi, Sunil Abhyankar, Joseph P McGuirk, Siddartha Ganguly, Bio of Blood and Marrow Transp, 1/1/2015
  • Peripheral-blood stem cells versus bone marrow from unrelated donors  
    Anasetti C1, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, Ehninger G, Johnston L, Maziarz RT, Pulsipher MA, Por..., N Engl J Med, 1/18/2012
  • Join now to see all

Abstracts/Posters

  • The prognosis of NF1 mutations in newly diagnosed AML, A single-center retrospective study.
    Mohammad Telfah, Haitham Abdelhakim, Eyad Gharaibeh, Nicole Balmaceda, Andrew K. Godwin, Ziyan Pessetto, Joseph McGuirk, and Tara L. Lin, ASCO, 1/1/2019
  • 2046 / 27 - Egr-1 promotes bone marrow fibrosis in primary myelofibrosis
    Rekha M. Rao, Amar Kumar, Pratikkumar Vekaria, Abdulraheem Yacoub, Barry Skikne, Joseph McGuirk, AACR Annual Meeting, Atlanta, GA, 1/1/2019
  • An Updated Analysis of Juliet, A Global Pivotal Phase 2 Trial of Tisagenlecleucel In Adult Patients With Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DL...
    Peter Borchmann , Constantine S. Tam, Ulrich J�ger, Joseph P. McGuirk, Harald Holte, Edmund K. Waller, Samantha M. Jaglowski, Michael R. Bishop, Charalambos Andreadis,..., EHA, 1/1/2018
  • Join now to see all

Lectures

  • Overview/Update on the Bone Marrow Transplantation Program 
    Topeka, KS - 1/1/2014
  • Delayed Diagnosis of RSV Infection in a Stem Cell Transplant Population Using a Commercially Available Molecular Detection Assay 
    1/1/2012
  • Recovery of Oral Mucositis Following Ablative Umbilical Cord Blood Transplantation is Independent of Neutrophil Recovery. 
    1/1/2012
  • Join now to see all

Other

  • Final Results of the First in Human Clinical Study Incorporating Hyperbaric Oxygen Into Autologous Stem Cell Transplantation. 
    Leyla Shune, Siddhartha Ganguly, Tara L. Lin, Jonathan Mahnken, Jennifer Bunch, Stacy Supancic, Anurag K. Singh, Sunil Abhyankar, Dennis Allin, Joseph McGuirk, Omar Al...
    http://dx.doi.org/10.1016/j.bbmt.2016.12.265
    1/1/2017
  • Using Helper T Cell Function to Predict the Response of Chronic GVHD Patients to ECP Therapy 
    Thomas Yankee, Daisy Dai, Jignesh D. Dalal, Ashraf Hassaballa, Siddhartha Ganguly, Joseph McGuirk, Sunil Abhyankar
    http://dx.doi.org/10.1016/j.bbmt.2016.12.305
    1/1/2017
  • Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia. 
    Betty Ky Hamilton, Lisa Rybicki, Donna Abounader, Kehinde Adekola, Anjali Advani, Ibrahim Aldoss, Veronika Bachanova, Asad Bashey, Stacey Brown, Marcos DeLima, Steven ...
    https://doi.org/10.1016/j.bbmt.2017.04.003
    1/1/2017
  • Join now to see all

Press Mentions

  • 'It's Life-Saving': Missouri Medicaid Could Cover Gene Therapy for Sickle Cell Patients
    'It's Life-Saving': Missouri Medicaid Could Cover Gene Therapy for Sickle Cell PatientsOctober 8th, 2024
  • CRISPR Gene-Editing May Boost Cancer Immunotherapy, New Study Finds
    CRISPR Gene-Editing May Boost Cancer Immunotherapy, New Study FindsDecember 13th, 2022
  • AlloVir Announces Positive Final Results in Phase 2 Posoleucel Multi-Virus Prevention Study in Oral Presentation at the 64th ASH Annual Meeting and Exposition
    AlloVir Announces Positive Final Results in Phase 2 Posoleucel Multi-Virus Prevention Study in Oral Presentation at the 64th ASH Annual Meeting and ExpositionDecember 10th, 2022
  • Join now to see all

Dr. Joseph McGuirk, Dr. Joseph McGuirk, DO, Dr. J McGuirk, Dr. Joseph Patrick McGuirk